Home NDC 65219-622 acyclovir
Product NDC 65219-622
11-digit product format 652190622
Labeler code 65219
Product ID 65219-622_a2fee863-ed62-4501-881d-eab609ebd51d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACYCLOVIR
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Fresenius Kabi USA, LLC
Application ANDA215404
Marketing category ANDA
Marketing start 2024-12-16
Substance ACYCLOVIR SODIUM
Active strength 50 mg/mL
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base acyclovir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR SODIUM 50 mg/mL
Harmonized Identifiers# Field, Values table Field Values Unii 927L42J563 Rxcui 1734932, 1734934
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65219-622-02 acyclovir 10 mL in 1 VIAL INJECTION, SOLUTION 10 1 65219-622-10 acyclovir 10 in 1 CARTON INJECTION, SOLUTION 10 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65219-622 ACYCLOVIR INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] 1 Current NDC, 2 package rows 20241217_b1bb347d-74f4-4976-8450-a375a271718f.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 65219-622-02 65219062202 10 mL in 1 VIAL 10 ml Historical 65219-622-10 65219062210 10 VIAL in 1 CARTON (65219-622-10) / 10 mL in 1 VIAL (65219-622-02) 10 vial 2024-12-16 No No Historical